A nationwide recall has been initiated for levothyroxine sodium tablets, a commonly prescribed drug used to treat hypothyroidism and goiter, among other conditions. The recall is limited to some lots of levothyroxine sodium tablets distributed by Major Pharmaceuticals. The tablets were found to be ‘subpotent,’ meaning they deliver less medication than intended, according to the FDA’s report.
What to Do
If you discover your medication is affected by the recall, reach out to your doctor or pharmacist for advice on how to proceed. Do not discontinue your medication unless directed to do so by a healthcare provider, as in some cases, suddenly stopping a drug can cause ill effects.
Recalled tablets were packaged in 10-count blister packs, which were either sold individually or bundled into cartons containing 10 blister packs. They can be identified by the lot numbers and expiration dates listed below.
- 25 mcg, 100-tablet carton: Lot number: N02212, Expiration date: 07/2026
- 50mcg, 100-tablet carton: Lot number: N02200, Expiration date: 10/2026
- 75mcg, 100-tablet carton: Lot number: N02172, N02296, N02288, Expiration date: 07/2026, 12/2026
- 88mcg, 100-tablet carton: Lot number: N02310, Expiration date: 01/2027
- 112mcg, 100-tablet carton: Lot number: N02203, Expiration date: 09/2026
- 125mcg, 100-tablet carton: Lot number: N02266, Expiration date: 11/2026
- 150mcg, 100-tablet carton: Lot number: N02167, Expiration date: 07/2026
Original reporting: WPBF (Treasure Coast / Hearst) — read the source article.
